Expert commentary with practical insights on the recent FDA approval and use of acalabrutinib in CLL from Clinical Care Options (CCO)
From Clinical Care Options (CCO), watch a CME-certified video from a symposium at AASLD 2019 featuring expert perspectives on evolving systemic therapy for HCC
This archived CE-certified Clinical Care Options webcast presents optimal nursing strategies for the management of patients with multiple myeloma.
Clinical Care Options (CCO) downloadable patient resource guide to help patients and their caregivers manage their treatment for head and neck cancer.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.